Valganciclovir Powder, For Solution
Product Images NDC 60687-765

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 60687-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 mg Per mL Valganciclovir Os Bottle (50 mg Per mL Valganciclovir Os Bottle)

Label for Valganciclovir for Oral Solution 50 mg/mL, a powder for solution oral dosage form. The label indicates a 100 mL (3.4 fl oz) bottle containing valganciclovir free base. It shows preparation and storage instructions, pharmacist directions, manufacturer Annora Pharma Pvt. Ltd. in India, and distributor American Health Packaging in Columbus, Ohio. Includes NDC 60687-765-13, barcode, and batch coding area.*

FDA Label Image

50 mg Per mL Valganciclovir Os Carton (50 mg Per mL Valganciclovir Os Carton)

Label for Valganciclovir for Oral Solution 50 mg/mL by American Health Packaging. The label indicates a 100 mL (3.4 fl oz) powder for solution dosage form. Instructions for preparation, storage conditions, and dispensing details are provided. The product NDC is 60687-765-13, with distribution by American Health Packaging, Columbus, Ohio.*

FDA Label Image

Figure 1 (Figure 1)

An instructional diagram showing components of a medication bottle and an oral dispenser. The bottle assembly includes a child resistant cap, bottle adapter, and bottle. The oral dispenser consists of a plunger, barrel with measurement markings, and a tip for delivering the oral medication.*

FDA Label Image

Step 1 (Step 1)

Illustration showing a hand holding a bottle of oral powder for solution with an instruction to shake well before use.*

FDA Label Image

Step 10 A (Step 10 A)

An instructional illustration showing a faucet with water droplets falling onto two oral syringes positioned below. The image likely depicts rinsing or cleaning of syringes with water.*

FDA Label Image

Step 10 B (Step 10 B)

An illustration of a syringe with a plunger and measurement markings along the barrel, commonly used for administering or measuring liquid medication doses.*

FDA Label Image

Step 2 (Step 2)

Illustration showing proper technique to open a bottle containing medication by turning the cap in the direction indicated by an arrow, likely to break the seal or child-resistant closure.*

FDA Label Image

Step 3 (Step 3)

An instructional diagram showing a dosage indicator in milliliters (mL) on a measuring device, likely a syringe or dispenser, with labeled measurement marks for oral liquid medication.*

FDA Label Image

Step 4 (Step 4)

An instructional illustration showing a hand pressing down on a plunger of an oral dosing syringe, demonstrating how to use the syringe for administration.*

FDA Label Image

Step 5 (Step 5)

An instructional illustration showing the use of a bottle adapter opening device. The image depicts a hand holding a syringe positioned above the bottle adapter opening on a bottle, demonstrating the method for accessing the bottle contents.*

FDA Label Image

Step 6 (Step 6)

An instructional illustration depicting how to prepare an oral solution using a powder vial and a syringe. The image shows a hand holding a medicine vial upside down while a syringe is inserted to draw the liquid, demonstrating proper technique for medication reconstitution or withdrawal.*

FDA Label Image

Step 7 (Step 7)

An instructional illustration showing a hand pulling up a plunger in a syringe that is inserted into a vial, indicating the step to draw liquid from the vial into the syringe.*

FDA Label Image

Step 8 (Step 8)

An instructional illustration showing a person receiving oral administration of medication using an oral syringe. The syringe is inserted into the person's mouth, positioned for liquid medication delivery.*

FDA Label Image

Step 9 (Step 9)

An instructional illustration showing a vial with a cap and an arrow indicating a twisting motion to open the cap. The image depicts how to open a vial or bottle, likely related to the Valganciclovir oral powder for solution product.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of Valganciclovir Hydrochloride depicted as a molecular diagram showing its constituent atoms and bonds, including amine, hydroxyl, and heterocyclic groups alongside the hydrochloride component.*

FDA Label Image

Creatinine Clearance In Adults (Creatinine Clearance In Adults)

An illustration showing a formula to calculate a value for males based on age in years, body weight in kilograms, and serum creatinine level in mg/dL. The formula is: (140 minus age in years) times body weight in kg divided by 72 times serum creatinine in mg/dL.*

FDA Label Image

Modified Schwartz Formula (Modified Schwartz Formula)

Illustration showing two formulas used in pharmacokinetics: the Mosteller Body Surface Area (BSA) formula, calculating BSA as the square root of (Height in cm times Weight in kg) divided by 3600; and the Schwartz Creatinine Clearance formula, calculating clearance as a constant k times Height in cm divided by Serum Creatinine in mg/dL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.